|
Market Closed -
Nasdaq
00:00:00 09/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 20.56 USD | +1.58% |
|
+1.63% | -10.65% |
| 09-21 | Damora Therapeutics, Inc.(NasdaqCM:DMRA) added to S&P Global BMI Index | CI |
| 08-11 | Damora Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.58% | +1.63% | -29.52% | -25.32% | -10.65% | +93.05% | +29.51% | -75.67% | - | 1.25B | |
| -3.19% | -3.19% | +5.71% | +36.94% | +78.73% | +44.60% | +87.98% | +6.02% | - | 74.68B | |
| -15.86% | -16.67% | -18.84% | -13.12% | -1.56% | +3.92% | +50.90% | +170.03% | +4,686.97% | 58.7B | |
| -2.39% | -2.05% | +0.50% | -1.92% | +4.76% | +4.29% | +31.33% | -19.14% | +203.72% | 48.36B | |
| -6.35% | -8.63% | -9.26% | -0.87% | +136.18% | +293.39% | +638.59% | +577.18% | - | 43.05B | |
| +0.30% | -0.71% | -0.13% | +27.03% | +14.85% | +29.05% | +29.74% | +6.87% | +224.37% | 42.48B | |
| -3.82% | -2.41% | -0.38% | +15.98% | +15.25% | -0.27% | +102.63% | -3.61% | +990.41% | 41.39B | |
| -2.13% | +1.07% | -3.60% | +0.79% | +4.19% | +7.51% | +50.31% | +2.56% | +139.76% | 31.29B | |
| -3.35% | -4.95% | -6.69% | -1.57% | -3.30% | -13.38% | -15.78% | -62.57% | - | 23.93B | |
| -1.24% | -7.47% | -19.55% | -13.77% | -42.27% | -37.90% | +309.96% | +253.06% | +568.53% | 22.22B | |
| -5.27% | +0.55% | +10.04% | +24.23% | +16.23% | +12.57% | -5.34% | -16.04% | +107.39% | 22.24B | |
| -0.26% | +0.77% | +2.00% | +13.29% | +7.31% | +13.50% | +143.07% | +219.23% | +1,892.40% | 16.87B | |
| -0.83% | -1.65% | -9.81% | -11.33% | +182.04% | +139.28% | +356.14% | +1,992.52% | +684.56% | 15.67B | |
| -1.07% | +0.93% | +5.73% | +9.84% | +21.31% | +21.59% | +42.99% | -29.21% | +84.16% | 14.87B | |
| -2.50% | -2.03% | -17.55% | -19.66% | - | - | - | - | - | 15B | |
| -0.77% | +3.89% | +6.14% | +33.06% | +49.39% | +71.79% | +54.35% | -27.17% | +256.97% | 14.34B | |
| +0.99% | +1.86% | +2.34% | +5.19% | +34.66% | +52.74% | +174.64% | +172.99% | +368.04% | 14.48B | |
| -4.35% | +2.88% | -0.64% | +9.43% | -1.83% | -26.44% | +928.14% | +244.78% | +44.53% | 14.36B | |
| -1.52% | -9.44% | +7.76% | +20.97% | +17.32% | -32.90% | - | - | - | 12.69B | |
| +0.26% | +1.64% | +3.89% | -0.59% | -9.72% | -11.79% | -31.04% | -37.99% | +108.18% | 12.66B | |
| Average | -2.51% | -1.52% | -3.59% | +5.43% | +26.99% | +34.98% | +165.45% | +187.44% | +740.00% | 27.03B | |
| Weighted average by Cap. | -3.90% | -1.26% | -3.02% | +8.69% | +32.69% | +39.33% | +150.05% | +151.87% | +1,107.79% |
- Stock Market
- Stocks
- DMRA Stock
- Sector Damora Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
